{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:50Z","timestamp":1792686290609,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2015,9,16]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Most patients with atrial fibrillation (\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ) require rate control; however, the optimal target heart rate remains under debate. We aimed to assess rate control and subsequent outcomes among patients with permanent\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              .\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We studied 2812\n              <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content>\n              outpatients with permanent\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. Resting heart rate was measured longitudinally and used as a time\u2010dependent covariate in multivariable Cox models of all\u2010cause and cause\u2010specific mortality during a median follow\u2010up of 24\u00a0months. At baseline, 7.4% (n=207) had resting heart rate &lt;60\u00a0beats per minute (bpm), 62% (n=1755) 60 to 79\u00a0bpm, 29% (n=817) 80 to 109\u00a0bpm, and 1.2% (n=33) \u2265110\u00a0bpm. Groups did not differ by age, previous cerebrovascular disease, heart failure status,\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c scores, renal function, or left ventricular function. There were significant differences in race (\n              <jats:italic>P<\/jats:italic>\n              =0.001), sinus node dysfunction (\n              <jats:italic>P<\/jats:italic>\n              =0.004), and treatment with calcium\u2010channel blockers (\n              <jats:italic>P<\/jats:italic>\n              =0.006) and anticoagulation (\n              <jats:italic>P<\/jats:italic>\n              =0.009). In analyses of continuous heart rates, lower heart rate \u226465\u00a0bpm was associated with higher all\u2010cause mortality (adjusted hazard ratio [\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              ], 1.15 per 5\u2010bpm decrease; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 1.01 to 1.32;\n              <jats:italic>P<\/jats:italic>\n              =0.04). Similarly, increasing heart rate &gt;65\u00a0bpm was associated with higher all\u2010cause mortality (adjusted\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              , 1.10 per 5\u2010bpm increase; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 1.05 to 1.15;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.0001). This relationship was consistent across endpoints and in a broader sensitivity analysis of permanent and nonpermanent\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              patients.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Among patients with permanent\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              , there is a J\u2010shaped relationship between heart rate and mortality. These data support current guideline recommendations, and clinical trials are warranted to determine optimal rate control.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Clinical Trial Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">URL<\/jats:styled-content>\n              :\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/\">http:\/\/clinicaltrials.gov\/<\/jats:ext-link>\n              . Unique identifier: NCT01165710.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.002031","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T01:40:37Z","timestamp":1442281237000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":58,"title":["Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT\u2010AF)"],"prefix":"10.1161","volume":"4","author":[{"given":"Benjamin A.","family":"Steinberg","sequence":"first","affiliation":[{"name":"Duke University Medical Center, Durham, NC"},{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghee","family":"Kim","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[{"name":"UCLA Division of Cardiology, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Holmqvist","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Hylek","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[{"name":"Lankenau Institute for Medical Research, Wynnewood, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Palo Alto, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Naccarelli","sequence":"additional","affiliation":[{"name":"Penn State University School of Medicine, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Reiffel","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chang","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceuticals, Inc., Raritan, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, NC"},{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, NC"},{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT\u2010AF) Investigators and Patients","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.07.022"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021375"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021328"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.12.019"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001337"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1002301"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs253"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000041"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.07.001"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"e_1_3_4_13_2","first-page":"751","article-title":"Quality of care, symptoms, and 1\u00a0year outcomes for women vs men with atrial fibrillation: primary results from the ORBIT\u2010AF registry","author":"Piccini JP","year":"2013","unstructured":"Piccini JP, Kim S, Steinberg BA, Holmes D, Ansell J, Fonarow G, Gersh B, Hylek E, Kowey PR, Mahaffey KW, Thomas L, Chang P, Peterson E. Quality of care, symptoms, and 1\u00a0year outcomes for women vs men with atrial fibrillation: primary results from the ORBIT\u2010AF registry. J Am Coll Cardiol. 2013; Abstract: 751\u2013758.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.002927"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31820f14c0"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90836-2"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.04.030"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eul106"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.02.033"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.002031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:11:49Z","timestamp":1715595109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,16]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9,16]]}},"alternative-id":["10.1161\/JAHA.115.002031"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.002031","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,16]]},"assertion":[{"value":"2015-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-09-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e002031"}}